2 October 2024 - NiCE has published final evidence-based recommendations on the use of netarsudil mesylate with latanoprost (Roclanda) for the treatment of adults with primary open-angle glaucoma or ocular hypertension.

Netarsudil mesylate with latanoprost is recommended as an option for reducing intra-ocular pressure in adults with primary open-angle glaucoma or ocular hypertension when a prostaglandin analogue alone has not reduced intra-ocular pressure enough, only if:

• They have then tried a fixed-dose combination treatment and it has not reduced intra-ocular pressure enough, or
• The use of a fixed dose combination treatment containing an adrenergic beta receptor antagonist is unsuitable

Read NICE Technology appraisal guidance